Partner | Corporate and Commercial, Private Equity, Pharmaceuticals
- T: +91 22 6636 5000
- E: Write to me
education
- B.Sc., LL.B., (Hons.), National Law University, Jodhpur (2007)
Sameer Sah is Partner in the Corporate and Commercial Practice Group in the Mumbai office. Sameer specialises in the areas of strategic M&A, joint ventures, collaborations, foreign investments, private equity, and regulatory approvals for investing in India. He also advises clients on regulatory and other issues pertaining to the pharmaceutical, healthcare, retail and franchising sectors.
Professional Affiliations
- Bar Council of Maharashtra & Goa
- International Bar Association
- Association Internationale des Jeunes Avocats
- All India Federation of Tax Practitioners
- Chamber of Tax Consultants
- American Bar Association (Health Law and International Law Section)
- American Health Lawyers Association
Representative Matters
Sameer Sah has represented and advised the following clients
Reliance Jio
Advised on acquisition of the mobile business assets (including the spectrum, mobile towers and optical fibre network) of Reliance Communications.
Ingenico Group
Advised as an Indian Legal Counsel on acquisition of 100% of TechProcess Payment Services Limited.
GlaxoSmithKline Plc (GSK)
Advised on its three-part global transaction with Novartis AG (Novartis), pursuant to which GSK is forming a consumer health joint venture with Novartis, while at the same time buying Novartis’ vaccines business and divesting its cancer drugs portfolio to Novartis.
Mitsui & Co. (Asia Pacific) Pte. Ltd
Advised on acquisition of a minority stake in Keimed Private Limited.
Otsuka Pharmaceutical Factory, Inc. and Mitsui & Co., Ltd
Advised on their joint venture with Claris Lifesciences Limited.
Advent International Corporation
Advised on their affiliates’ investment of US$105 million in Quality Care India Limited.
Eris Lifesciences Private Limited
Advised on the stake purchase by Chrys Capital.
Lyndsay Goldberg
Advised on (i) divestment of their investment in Weener Plastik AG, and (ii) on the investment in Weener Plastik AG.
Meiji-Seika Pharma
Advised on acquisition of Medreich Limited.
Publications
Ergo Update
Ergo Update
Ergo Newsflash
Ergo Update
Ergo Update
Ergo Update
